CSCI

COSCIENS Biopharma Inc. Common Stock
CSCI

Overview Fund Activity
Delisted

CSCI was delisted on the 3rd of September, 2025.

Back to rankings

29 hedge funds and large institutions have $318K invested in COSCIENS Biopharma Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
29
Holders Change
+6
Holders Change %
+26.09%
% of All Funds
0.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
4
Reduced
8
Closed
2
Calls
$44K
Puts
$209K
Net Calls
-$165K
Net Calls Change
+$40K

Top Buyers

1
Morgan Stanley
Morgan Stanley
New York
$59K
2
Citadel Advisors
Citadel Advisors
Florida
$35K
3
Millennium Management
Millennium Management
New York
$20K
4
TSS
Two Sigma Securities
New York
$8K
5
FDCDDQ
Federation des caisses Desjardins du Quebec
Quebec, Canada
$24.1K

Top Sellers

1
Renaissance Technologies
Renaissance Technologies
New York
$0
2
VF
Virtu Financial
New York
$10K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
$37K
4
Two Sigma Advisers
Two Sigma Advisers
New York
$3K
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
$4K
Name Holding Trade Value Shares
Change 		Shares
Change %
Citigroup
26
Citigroup
New York
$1K +$1K +39 New
Bank of America
27
Bank of America
North Carolina
$1K +$1K +50 New
Bank of Montreal
28
Bank of Montreal
Ontario, Canada
$2 – -24 -19%
Renaissance Technologies
29
Renaissance Technologies
New York
– -$62K -1,676 Closed
1
2